Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Tables)

v3.24.1.1.u2
Basis of Presentation and Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of Potentially Dilute Loss Per Share
Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at March 31, 2024 and 2023 are as follows:
March 31,
2024 2023
Series A preferred stock 3,146 190,994
Series B preferred stock 33,883 2,047,359
Series C preferred stock 9,346 560,757
Series D preferred stock - 2,289,247
Series E preferred stock - 5,000,000
Convertible notes - 216,530
Series F preferred stock 501,579 -
Series F-1 preferred stock 72,631 -
Series F-2 preferred stock 124,946 -
Warrants to purchase common stock (excluding penny warrants) 2,470,078 599,576
Warrants to purchase Series E preferred stock 750,000 750,000
Options to purchase common stock 632,779 157,058
Unvested restricted stock units 1,124,527 8,299
Commitment shares 212,890 31,724
Total 5,935,805 11,851,544